| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Cost of Revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $455.00M | $479.00M | $481.00M | $467.00M | $441.00M |
| SG&A | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B |
| Operating Income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B |
| Interest Expense | $112.00M | $96.00M | $95.00M | $84.00M | $81.00M |
| Tax Expense | $132.00M | $232.00M | $99.00M | $250.00M | $150.00M |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| EPS (basic) | 4.5900 | 4.4400 | 4.2200 | 4.1900 | 3.9800 |
| EPS (diluted) | 4.5700 | 4.4300 | 4.1900 | 4.1800 | 3.9400 |
| Shares (diluted) | $285.00M | $291.00M | $296.00M | $300.00M | $307.00M |